Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2003;23:1352-1357
Published online before print June 26, 2003, doi: 10.1161/01.ATV.0000083297.47245.DA
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
23/8/1352    most recent
01.ATV.0000083297.47245.DAv1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Virdis, A.
Right arrow Articles by Schiffrin, E. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Virdis, A.
Right arrow Articles by Schiffrin, E. L.
Related Collections
Right arrow Remodeling
Right arrow Animal models of human disease
Right arrow Pathophysiology
Right arrow Genetically altered mice
Right arrow Endothelium/vascular type/nitric oxide
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2003;23:1352.)
© 2003 American Heart Association, Inc.


Vascular Biology

Effect of Hyperhomocystinemia and Hypertension on Endothelial Function in Methylenetetrahydrofolate Reductase–Deficient Mice

Agostino Virdis*; Marc Iglarz*; Mario Fritsch Neves; Farhad Amiri; Rhian M. Touyz; Rima Rozen; Ernesto L. Schiffrin

From the Multidisciplinary Research Group on Hypertension, Clinical Research Institute of Montreal, University of Montreal, and Montreal Children’s Hospital Research Institute (R.R.), McGill University, Montreal, Quebec, Canada.

Correspondence to Ernesto L. Schiffrin, MD, PhD, FRCPC, Clinical Research Institute of Montreal, 110 Pine Ave W, Montreal, Quebec, Canada H2W 1R7. E-mail schiffe{at}ircm.qc.ca

Objective— We evaluated the effect of hyperhomocystinemia and angiotensin (Ang) II on vascular function and structure in methylenetetrahydrofolate reductase knockout mice (Mthfr+/-).

Methods and Results— Mthfr+/- and controls (Mthfr+/+) received Ang II (400 ng/kg per min SC) or saline (14 days). Blood pressure, similar in Mthfr+/- and Mthfr+/+, was increased by Ang II. Acetylcholine- and bradykinin-induced relaxations were impaired in mesenteric resistance arteries (pressurized myograph) in Mthfr+/- and in Ang II–infused Mthfr+/+ mice and additionally blunted in Ang II–infused Mthfr+/- mice. The inhibition by L-NAME on acetylcholine was reduced in Mthfr+/- and in Ang II–Mthfr+/+ and absent in Ang II–Mthfr+/- mice. In these groups, vitamin C improved the response to acetylcholine and restored the inhibition by L-NAME. The media to lumen ratio of small arteries, similar in Mthfr+/- and Mthfr+/+, was increased by Ang II. Vascular NADPH oxidase activity, similar in Mthfr+/- and Mthfr+/+, increased after Ang II infusion. Vascular xanthine oxidase activity was also similar in Mthfr+/- and Mthfr+/+. Superoxide production in the aorta was reduced by sepiapterin and by L-NAME, suggesting that reduced bioavailability of tetrahydrobiopterin and uncoupling of nitric oxide synthase were the origin of increased reactive oxygen species in this model.

Conclusions— Mthfr+/- mice show endothelial dysfunction of mesenteric vessels probably attributable to a reduced nitric oxide bioavailability caused by oxidative excess due to uncoupling of nitric oxide synthase without vascular structural alterations. Concurrent Ang II–induced hypertension additionally reduced nitric oxide, increased NADPH oxidase activity, and induced structural alterations. Our findings suggest additive adverse effect of Ang II–dependent hypertension and hyperhomocystinemia on endothelial function.


Key Words: angiotensin • endothelium • free radicals • nitric oxide • small arteries




This article has been cited by other articles:


Home page
HypertensionHome page
C. Marchesi, T. Ebrahimian, O. Angulo, P. Paradis, and E. L. Schiffrin
Endothelial Nitric Oxide Synthase Uncoupling and Perivascular Adipose Oxidative Stress and Inflammation Contribute to Vascular Dysfunction in a Rodent Model of Metabolic Syndrome
Hypertension, December 1, 2009; 54(6): 1384 - 1392.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. Virdis, R. Colucci, D. Versari, N. Ghisu, M. Fornai, L. Antonioli, E. Duranti, E. Daghini, C. Giannarelli, C. Blandizzi, et al.
Atorvastatin Prevents Endothelial Dysfunction in Mesenteric Arteries From Spontaneously Hypertensive Rats: Role of Cyclooxygenase 2-Derived Contracting Prostanoids
Hypertension, June 1, 2009; 53(6): 1008 - 1016.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. Virdis, R. Colucci, M. Fornai, A. Polini, E. Daghini, E. Duranti, N. Ghisu, D. Versari, A. Dardano, C. Blandizzi, et al.
Inducible Nitric Oxide Synthase Is Involved in Endothelial Dysfunction of Mesenteric Small Arteries from Hypothyroid Rats
Endocrinology, February 1, 2009; 150(2): 1033 - 1042.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
R. Siekmeier, T. Grammer, and W. Marz
Roles of Oxidants, Nitric Oxide, and Asymmetric Dimethylarginine in Endothelial Function
Journal of Cardiovascular Pharmacology and Therapeutics, December 1, 2008; 13(4): 279 - 297.
[Abstract] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Ebrahimian, M. R. Sairam, E. L. Schiffrin, and R. M. Touyz
Cardiac hypertrophy is associated with altered thioredoxin and ASK-1 signaling in a mouse model of menopause
Am J Physiol Heart Circ Physiol, October 1, 2008; 295(4): H1481 - H1488.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Dayal and S. R. Lentz
Murine Models of Hyperhomocysteinemia and Their Vascular Phenotypes
Arterioscler Thromb Vasc Biol, September 1, 2008; 28(9): 1596 - 1605.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. J. Brosnan
One Step Beyond: Glutathione Peroxidase and Endothelial Dysfunction
Hypertension, April 1, 2008; 51(4): 825 - 826.
[Full Text] [PDF]


Home page
HypertensionHome page
A. Virdis, R. Colucci, M. Fornai, E. Duranti, C. Giannarelli, N. Bernardini, C. Segnani, C. Ippolito, L. Antonioli, C. Blandizzi, et al.
Cyclooxygenase-1 Is Involved in Endothelial Dysfunction of Mesenteric Small Arteries From Angiotensin II-Infused Mice
Hypertension, March 1, 2007; 49(3): 679 - 686.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. M. Wilson, R. B. McCaw, L. Leo, E. Arning, S. Lhotak, T. Bottiglieri, R. C. Austin, and S. R. Lentz
Prothrombotic Effects of Hyperhomocysteinemia and Hypercholesterolemia in ApoE-Deficient Mice
Arterioscler Thromb Vasc Biol, January 1, 2007; 27(1): 233 - 240.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
L. G. Mikael, J. Genest Jr, and R. Rozen
Elevated Homocysteine Reduces Apolipoprotein A-I Expression in Hyperhomocysteinemic Mice and in Males With Coronary Artery Disease
Circ. Res., March 3, 2006; 98(4): 564 - 571.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. De Ciuceis, F. Amiri, P. Brassard, D. H. Endemann, R. M. Touyz, and E. L. Schiffrin
Reduced Vascular Remodeling, Endothelial Dysfunction, and Oxidative Stress in Resistance Arteries of Angiotensin II-Infused Macrophage Colony-Stimulating Factor-Deficient Mice: Evidence for a Role in Inflammation in Angiotensin-Induced Vascular Injury
Arterioscler Thromb Vasc Biol, October 1, 2005; 25(10): 2106 - 2113.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Dayal, A. M. Devlin, R. B. McCaw, M.-L. Liu, E. Arning, T. Bottiglieri, B. Shane, F. M. Faraci, and S. R. Lentz
Cerebral Vascular Dysfunction in Methionine Synthase-Deficient Mice
Circulation, August 2, 2005; 112(5): 737 - 744.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
D. Li, L. Pickell, Y. Liu, Q. Wu, J. S Cohn, and R. Rozen
Maternal methylenetetrahydrofolate reductase deficiency and low dietary folate lead to adverse reproductive outcomes and congenital heart defects in mice
Am. J. Clinical Nutrition, July 1, 2005; 82(1): 188 - 195.
[Abstract] [Full Text] [PDF]


Home page
Vasc MedHome page
S. Dayal and S. R Lentz
ADMA and hyperhomocysteinemia
Vascular Medicine, July 1, 2005; 10(1_suppl): S27 - S33.
[Abstract] [PDF]


Home page
Vasc MedHome page
S. Dayal and S. R Lentz
ADMA and hyperhomocysteinemia
Vascular Medicine, May 1, 2005; 10(2_suppl): S27 - S33.
[Abstract] [PDF]


Home page
CirculationHome page
F. Amiri, A. Virdis, M. F. Neves, M. Iglarz, N. G. Seidah, R. M. Touyz, T. L. Reudelhuber, and E. L. Schiffrin
Endothelium-Restricted Overexpression of Human Endothelin-1 Causes Vascular Remodeling and Endothelial Dysfunction
Circulation, October 12, 2004; 110(15): 2233 - 2240.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
D. H. Endemann and E. L. Schiffrin
Endothelial Dysfunction
J. Am. Soc. Nephrol., August 1, 2004; 15(8): 1983 - 1992.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. M. Devlin, E. Arning, T. Bottiglieri, F. M. Faraci, R. Rozen, and S. R. Lentz
Effect of Mthfr genotype on diet-induced hyperhomocysteinemia and vascular function in mice
Blood, April 1, 2004; 103(7): 2624 - 2629.
[Abstract] [Full Text] [PDF]